{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:57:17Z","timestamp":1776142637710,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011912","name":"Washington University in St Louis School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.rmed.2026.108717","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:19:00Z","timestamp":1771546740000},"page":"108717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and feasibility of provider implementation tools for anti-inflammatory reliever therapy in community asthma practices"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-2966","authenticated-orcid":false,"given":"Kaharu","family":"Sumino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alden","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel","family":"Tapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Krings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna D.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-3217","authenticated-orcid":false,"given":"Jane","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Zulich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Tueme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Clover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-5661","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.108717_bib1","series-title":"Trends in Asthma Prevalence, Health Care Use, and Mortality in the United States, 2001-2010","first-page":"1","author":"Akinbami","year":"2012"},{"key":"10.1016\/j.rmed.2026.108717_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1398-9995.2007.01394.x","article-title":"Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations","volume":"62","author":"Dusser","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.108717_bib4","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jaip.2022.02.047","article-title":"Short-acting Beta-2-Agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America","volume":"10","author":"Quint","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.108717_bib5","series-title":"Global Initiative for Asthma (GINA)","year":"2019"},{"key":"10.1016\/j.rmed.2026.108717_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 focused updates to the asthma management guidelines: a report from the national asthma education and prevention program coordinating committee expert panel working group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.108717_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048537","article-title":"Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study","volume":"12","author":"Foster","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2026.108717_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02073-2019","article-title":"Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial","volume":"55","author":"Baggott","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108717_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaip.2019.06.030","article-title":"A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma","volume":"8","author":"Sumino","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.108717_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/02770900903580850","article-title":"Treatment adherence among low-income, African American children with persistent asthma","volume":"47","author":"Celano","year":"2010","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2026.108717_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/02770900802712971","article-title":"Urban minority children with asthma: substantial morbidity, compromised quality and access to specialists, and the importance of poverty and specialty care","volume":"46","author":"Flores","year":"2009","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2026.108717_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1513\/AnnalsATS.201209-076BC","article-title":"Reactive versus proactive patterns of inhaled corticosteroid use","volume":"10","author":"Sloan","year":"2013","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2026.108717_bib13","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-Needed budesonide-formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108717_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.108717_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2026.108717_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ebch.1988","article-title":"Inhaled corticosteroids in children with persistent asthma: effects on growth","volume":"9","author":"Zhang","year":"2014","journal-title":"Evid. Base Child Health"},{"key":"10.1016\/j.rmed.2026.108717_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1440-1843.2009.01589.x","article-title":"Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis","volume":"14","author":"Weatherall","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2026.108717_bib18","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O'Byrne","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108717_bib19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108717_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa2504544","article-title":"As-Needed albuterol-budesonide in mild asthma","volume":"393","author":"LaForce","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108717_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chest.2023.09.004","article-title":"Implementing antiinflammatory reliever strategies in asthma: the evolving paradigm of asthma management","volume":"165","author":"Zaeh","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.108717_bib22","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.jaip.2023.05.023","article-title":"Beginning to address an implementation gap in asthma: clinicians' views of prescribing reliever budesonide-formoterol inhalers and SMART in the United States","volume":"11","author":"Krings","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2026.108717_bib23","first-page":"29","article-title":"SUS: a retrospective","volume":"8","author":"Brooke","year":"2013","journal-title":"Journal of Usability Studies"},{"key":"10.1016\/j.rmed.2026.108717_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implement. Sci."},{"key":"10.1016\/j.rmed.2026.108717_bib25","first-page":"574","article-title":"An empirical evaluation of the system usability scale","volume":"24","author":"Bangor","year":"2008","journal-title":"Int J Hum-Comput Int."},{"key":"10.1016\/j.rmed.2026.108717_bib26","first-page":"577","article-title":"The system usability scale: Past, present, and future","volume":"34","author":"Lewis","year":"2018","journal-title":"Int J Hum-Comput Int."},{"key":"10.1016\/j.rmed.2026.108717_bib27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.rmed.2026.108717_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nedt.2017.06.002","article-title":"Methodological challenges in qualitative content analysis: a discussion paper","volume":"56","author":"Graneheim","year":"2017","journal-title":"Nurse Educ. Today"},{"key":"10.1016\/j.rmed.2026.108717_bib29","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.rmed.2026.108717_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12913-018-2938-8","article-title":"Qualitative approaches to use of the RE-AIM framework: rationale and methods","volume":"18","author":"Holtrop","year":"2018","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.rmed.2026.108717_bib31","first-page":"228","article-title":"A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice","volume":"34","author":"Feldstein","year":"2008","journal-title":"Joint Comm. J. Qual. Patient Saf."},{"key":"10.1016\/j.rmed.2026.108717_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-2600(20)30416-1","article-title":"Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study","volume":"9","author":"O'Byrne","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.108717_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.108717_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00174-2024","article-title":"Real-world use of inhaled corticosteroid\/formoterol as needed in adults with mild asthma: the PRIME study","volume":"10","author":"Brusselle","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2026.108717_bib36","article-title":"Patterns of asthma medication use and hospital discharges in New Zealand","volume":"3","author":"Noble","year":"2024","journal-title":"J Allergy Clin Immunol Glob."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:24:38Z","timestamp":1776140678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"alternative-id":["S0954611126000855"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108717","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and feasibility of provider implementation tools for anti-inflammatory reliever therapy in community asthma practices","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108717"}}